Effects and mechanisms of glucosides of chaenomeles speciosa on collagen-induced arthritis in rats

International Immunopharmacology

Volumn 3, Issue 4, 2003, Pages 593-608

  Chen, Qun ^a   Wei, Wei ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Collagen induced arthritis rats; Cyclic AMP; G protein; Signal transduction; Synoviocytes

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIBODY; COLLAGEN; COLLAGEN TYPE 2; CYCLIC AMP; GLUCOSIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; CHAENOMELES SPECIOSA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HERBAL MEDICINE; HINDLIMB; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; MALE; NONHUMAN; ORGAN WEIGHT; PATHOGENESIS; PLANT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYNOVIOCYTE; WEIGHT REDUCTION;

EID: 0037387303     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00051-1     Document Type: Article

References (45)

1. Silman A.J. Epidemiology of rheumatoid arthritis. APMIS. 102:1994;721-728.
2. Lynn A.H., Kwoh C.K., Venglish C.M., Aston C.E., Chakravarti A. Genetic epidemiology of rheumatoid arthritis. Am. J. Hum. Genet. 57:1995;150-159.
3. Kwoh C.K., Venglish C., Lynn A.H., Whitley D.M., Young E., Chakravarti A. Age, sex, and the familial risk of rheumatoid arthritis. Am. J. Epidemiol. 144:1996;15-24.
4. Trentham D.E., Townes A.S., Kang A.H. Autoimmunity to type II collagen an experimental model of arthritis. J. Exp. Med. 146:1977;857-868.
5. Remmers E.F., Joe B., Griffiths M.M., Dobbins D.E., Dracheva S.V.et al. Modulation of multiple experimental arthritis models by collagen-induced arthritis quantitative trait loci isolated in congenic rat lines: different effects of non-major histocompatibility complex quantitative trait loci in males and females. Arthritis Rheum. 46:2002;2225-2234.
6. Lu S., Carlsen S., Hansson A.S., Holmdahl R. Immunization of rats with homologous type XI collagen leads to chronic and relapsing arthritis with different genetics and joint pathology than arthritis induced with homologous type II collagen. J. Autoimmun. 18:2002;199-211.
7. Backlund J., Treschow A., Firan M., Malmstrom V., Issazadeh-Navikas S.et al. Reversal of tolerance induced by transplantation of skin expressing the immunodominant T cell epitope of rat type II collagen entitles development of collagen-induced arthritis but not graft rejection. Eur. J. Immunol. 32:2002;1773-1783.
8. Li H., Jia Y.F., Pan Y., Pan D.J., Li D., Zhang L.X. Effect of tripterine on collagen-induced arthritis in rats. Acta Pharm. Sin. 18:1997;270-273.
9. Courtenay J.S., Dallman M.J., Dayan A.D., Martin A., Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 283:1980;666-668.
10. Wooley P.H., Luthra H.S., Stuart J.M., David C.S. Type II collagen-induced arthritis in mice: I. Major histocompatibility complex (I region) linkage and antibody correlates. J. Exp. Med. 154:1981;688-700.
11. Sun L.N., Hong Y.F., Guo X.M. Studies on the chemical constituents of Chaenomeles sinensis (Thouin.) Koehne. Chin. Tradit. Herb. Drugs. 30:1999;25. [Suppl.].
12. Sun L.N., Hong Y.F., Guo X.M., Yang G.J., Zhang G.M. Studies on the chemical constituents of Chaenomeles sinensis (Thouin.) Koehne. Acad. J. Second Mil. Med. Univ. 20:1999;752-754.
13. Wang B., Yao Y.Y., Zhou A.W., Ge Z.D., Chen M.Z., Xu S.Y. Protective effects of Total glucosides of paeony on joint damage in adjuvant arthritis rats. Chin. J. Pharmacol. Toxicol. 10:1996;211-214.
14. Fujisawa H., Nishimura T., Inoue Y., Ogaya S., Shibata Y.et al. Antiinflammatory properties of the new antirheumatic agent 4-acetylaminophenylacetic acid. Arzneimittelforschung. 40:1990 Jun. 693-697.
15. Fujisawa H., Nishimura T., Motonaga A., Inoue Y., Inoue K.et al. Effect of actarit on type II collagen-induced arthritis in mice. Arzneimittelforschung. 44:1994 Jan. 64-68.
16. Joosten L.A., Lubberts E., Durez P., Helsen M.M., Jacobs M.J.et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 40:1997;249-260.
17. Joosten L.A., Lubberts E., Helsen M.M., van den Berg W.B. Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J. Immunol. 159:1997;4094-4102.
18. Joosten L.A., Helsen M.M., van den Berg W.B. Accelerated onset of collagen-induced arthritis by remote inflammation. Clin. Exp. Immunol. 97:1994;204-211.
19. Caccese R.G., Zimmermann J.L., Carlson R.P. Bacterial lipopolysaccharide potentiates type II collagen-induced arthritis in mice. Mediat. Inflamm. 1:1992;273.
20. Cremer M.A., Hernandez A.D., Townes A.S., Stuart J.M., Kang A.H. Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. J. Immunol. 131:1983;2995-3000.
21. Hughes C., Wolos J.A., Giannini E.H., Hirsch R. Induction of T helper cell hyporesponsiveness in an experimental model of autoimmunity by using nonmitogenic anti-CD3 monoclonal antibody. J. Immunol. 153:1994;3319-3325.
22. Neale M.L., Williams B.D., Matthews N. Tumour necrosis factor activity in joint fluids from rheumatoid arthritis patients. Br. J. Rheumatol. 28:1989;104-108.
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
24. Katsikis P.D., Chu C.Q., Brennan F.M., Maini R.N., Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J. Exp. Med. 179:1994;1517-1527.
25. Lopez-Gonzalez M.A., Calvo J.R., Osuna C. Synergistic action of melatonin and vasoactive intestinal peptide in stimulating cyclic AMP production in human lymphocytes. J. Pineal Res. 12:1992;174-180.
26. Brackertz D., Mitchell G.F., Mackay I.R. Antigen-induced arthritis in mice. Arthritis Rheum. 20:1977;841-850.
27. Tak P.P., Smeets T.J., Daha M.R., Kluin P.M., Meijers K.A.et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum. 40:1997;217-225.
28. Firestein G.S., Zvaifler N.J. How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum. 33:1990;768-773.
29. Lupia E., Montrucchio G., Battaglia E., Modena V., Camussi G. Role of tumor necrosis factor-α and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis. Eur. J. Immunol. 26:1996;1690-1694.
30. Camussi G., Lapia E. The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis. Drugs. 55:1998;613-620.
31. Deleuran B.M.W., Chu C.Q., Field M. Localization of tumor necrosis factor receptors in the synovial tissue and cartilagepannus junction in patients with rheumatoid arthritis: implications for local actions of tumor necrosis factor-a. Arthritis Rheum. 35:1992;1170-1178.
32. Dinarello C.A. The interleukin-1 family: 10 years of discovery. FASEB J. 8:1994;1313-1325.
33. Feldmann M., Brennan F.M., Maini R.N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:1996;397-440.
34. Elliott M.J., Maini R.N., Feldmann M., Kalden J.R., Antoni C.et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet. 344:1994;1105-1110.
35. Moreland L.W., Baumgartner S.W., Schiff M.H., Tindall E.A., Fleischmann R.M.et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 337:1997;141-147.
36. Schoen R.T., Greene M.I., Trentham D.E. Antigen-specific suppression of type II collagen-induced arthritis by collagen-coupled spleen cells. J. Immunol. 128:1982;717-719.
37. Schoen R.T., Mehlman H., Trentham D.E., Perry L., Greene M.I., David J.R. Autoimmunity induced by type II collagen-coupled spleen cells. J. Immunol. 127:1981;2275-2279.
38. Chen Q., Wei W. Effects and mechanisms of melatonin on inflammatory and immune responses of adjuvant arthritis rat. Int. Immunopharmacol. 2:2002;1443-1449.
39. Jain S., Akiyama K., Mae K., Ohguchi T., Takata R. Targeted disruption of a G protein alpha subunit gene results in reduced pathogenicity in Fusarium oxysporum. Curr. Genet. 41:2002;407-413.
40. Prado M.A., Evans-Bain B., Dickerson I.M. Receptor component protein (RCP): a member of a multi-protein complex required for G-protein-coupled signal transduction. Biochem. Soc. Trans. 30:2002;460-464.
41. Clark G.B., Thompson G. Jr., Roux S.J. Signal transduction mechanisms in plants: an overview. Curr. Sci. 80:2001;170-177.
42. Mehlmann L.M., Jones T.L., Jaffe L.A. Meiotic arrest in the mouse follicle maintained by a Gs protein in the oocyte. Science. 297:2002;1343-1345.
43. Liu H.Y., Seifert R. Distinct interactions of G(salpha-long), G(salpha-short), and G(alphaolf) with GTP, ITP, and XTP. Biochem. Pharmacol. 64:2002;583-593.
44. Nanki T., Lipsky P.E. Stimulation of T-Cell activation by CXCL12/stromal cell derived factor-1 involves a G-protein mediated signaling pathway. Cell. Immunol. 214:2001;145-154.
45. Johnson E.N., Druey K.M. Heterotrimeric G protein signaling: role in asthma and allergic inflammation. J. Allergy Clin. Immunol. 109:2002;592-602.